Ginkgo Bioworks Holdings (DNA) Cash & Current Investments: 2019-2025
Historic Cash & Current Investments for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $111.1 million.
- Ginkgo Bioworks Holdings' Cash & Current Investments fell 81.98% to $111.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 62.04%. This contributed to the annual value of $561.6 million for FY2024, which is 40.52% down from last year.
- Ginkgo Bioworks Holdings' Cash & Current Investments amounted to $111.1 million in Q3 2025, which was down 45.44% from $203.6 million recorded in Q2 2025.
- In the past 5 years, Ginkgo Bioworks Holdings' Cash & Current Investments ranged from a high of $1.7 billion in Q3 2021 and a low of $111.1 million during Q3 2025.
- Its 3-year average for Cash & Current Investments is $698.3 million, with a median of $730.4 million in 2024.
- Per our database at Business Quant, Ginkgo Bioworks Holdings' Cash & Current Investments spiked by 483.80% in 2022 and then tumbled by 81.98% in 2025.
- Over the past 5 years, Ginkgo Bioworks Holdings' Cash & Current Investments (Quarterly) stood at $1.6 billion in 2021, then declined by 15.11% to $1.3 billion in 2022, then decreased by 28.25% to $944.1 million in 2023, then tumbled by 40.52% to $561.6 million in 2024, then crashed by 81.98% to $111.1 million in 2025.
- Its last three reported values are $111.1 million in Q3 2025, $203.6 million for Q2 2025, and $312.4 million during Q1 2025.